scPharmaceuticals Inc.

NASDAQ:SCPH

5.26 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Omzet 8.0546.1026.0963.7961.6382.0630000000000000000000000000000
Kosten van de omzet 2.3521.8361.7731.0790.3540.6050.120.1180.1280.1020.1110.1120.1090.10600000000000000000000
Brutowinst 5.7024.2664.3232.7171.2841.458-0.12-0.118-0.128-0.102-0.111-0.112-0.109-0.10600000000000000000000
Brutowinstmarge 0.7080.6990.7090.7160.7840.7070000000000000000000000000000
Onderzoek- en ontwikkelingskosten 2.6772.7263.3383.4212.9342.1162.3263.7185.1424.3474.533.6943.8074.0093.7455.1195.1394.1468.3184.2935.4966.5243.1493.8964.8554.0483.7163.5854.1452.8853.0173.6172.6112.611
Algemene en administratieve kosten 01.07522.992012.09610.8967.1766.2774.2792.8932.1912.2112.6492.7323.4253.3192.5372.5032.1151.9961.8392.3232.0741.9455.0494.6512.9921.6652.3742.0740.9432.161.4761.476
Verkoop- en marketingkosten 016.321-6.750000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 17.45617.39616.24214.13512.09610.8967.1766.2774.2792.8932.1912.2112.6492.7323.4253.3192.5372.5032.1151.9961.8392.3232.0741.9455.0494.6512.9921.6652.3742.0740.9432.161.4761.476
Overige kosten -1.1892.9722.412-0.0360.2390.991.363-0.0220.0640.0140.0170.010.0330.2550.0090.019-0.001-0.031-0.0450.083-0.014-0.0080.002-0.005-0.011-0.042-0.0070.0150.0570.010.027000
Bedrijfskosten 20.13320.12219.5817.55615.0313.0129.5029.9959.4217.246.7215.9056.4566.7417.178.4387.6766.64910.4336.2897.3358.8475.2235.8419.9048.6996.7085.256.5194.9593.965.7834.0784.078
Bedrijfsresultaat -14.431-15.856-15.257-14.839-13.746-11.554-9.502-9.995-9.421-7.24-6.721-5.905-6.456-6.741-7.17-8.438-7.676-6.649-10.433-6.289-7.335-8.847-5.223-5.841-9.904-8.699-6.708-5.25-6.519-4.959-3.96-5.777-4.087-4.087
Bedrijfsresultaat ratio -1.792-2.598-2.503-3.909-8.392-5.6010000000000000000000000000000
Totaal overige inkomsten en kosten netto -2.6591.7481.445-0.7950.2390.3440.254-0.167-0.276-0.4910.0170.010.0330.2550.0090.019-0.001-0.031-0.0450.083-0.014-0.0080.002-0.005-0.011-0.042-0.0070.0150.0570.010.027-3.307-0.901-0.901
Inkomen voor belasting -17.09-14.108-13.812-15.634-14.154-11.21-9.248-10.162-9.697-7.731-7.318-6.552-7.062-7.102-7.784-9.038-8.295-7.092-10.814-6.207-7.255-8.719-5.1-5.761-9.85-8.732-6.88-5.489-6.536-4.912-5.318-9.084-4.988-4.988
Inkomen voor belasting ratio -2.122-2.312-2.266-4.119-8.641-5.4340000000000000000000000000000
Belastingkosten 00.008-3.485-0.2722.141.6170.5140.1670.2760.4910.5970.6470.6060.3610.6140.60.6190.4430.381-0.082-0.08-0.128-0.123-0.08-0.0540.0330.1720.2390.017-0.0471.358000
Nettowinst -17.09-14.108-13.812-15.634-14.154-12.827-9.762-10.329-9.973-8.222-7.318-6.552-7.062-7.102-7.784-9.038-8.295-7.092-10.814-6.207-7.255-8.719-5.1-5.761-9.85-8.732-6.88-5.489-6.536-4.912-5.318-9.084-4.988-4.988
Nettowinstmarge -2.122-2.312-2.266-4.119-8.641-6.2180000000000000000000000000000
WPA (Winst Per Aandeel) -0.44-0.36-0.36-0.4-0.37-0.34-0.31-0.38-0.36-0.3-0.27-0.24-0.26-0.26-0.28-0.33-0.36-0.35-0.58-0.33-0.39-0.47-0.27-0.31-0.53-0.47-0.8-0.31-0.58-0.44-0.47-8.52-5.65-5.65
Verwaterde WPA -0.44-0.36-0.36-0.4-0.37-0.34-0.31-0.38-0.36-0.3-0.27-0.24-0.26-0.26-0.28-0.33-0.36-0.35-0.58-0.33-0.39-0.47-0.27-0.31-0.53-0.47-0.8-0.31-0.58-0.44-0.47-8.52-5.65-5.65
EBITDA -14.379-15.805-15.117-14.839-12.144-9.249-7.289-9.667-9.122-7.111-6.697-5.773-6.302-6.36-7.127-8.282-7.557-6.361-10.168-5.809-6.797-8.365-4.73-5.317-9.409-8.309-6.544-5.16-6.378-4.886-3.927-5.776-4.085-4.085
EBITDA ratio -1.785-2.59-2.48-3.909-7.414-4.4830000000000000000000000000000